PACCARB
June 21-22, 2016 - Public Meeting
The June public meeting was dedicated to presentations from federal and non-federal stakeholders surrounding topic areas related to incentives for the development of vaccines, diagnostics, and therapeutics. The topic of the environment and its intersection with antibiotic-resistance was also discussed.
Agenda
Webcast Information
Meeting Documents
March 2016 - Letter to the PACCARB Chair and Vice Chair - PDF
Presentations
Incentives and USG Experience
Incentives – International Experience
Incentives – Industry Experience
Plasmid-Mediated Colistin Resistance – U.S. Government Findings and Response
Antibiotic Resistance in the Healthcare Environment
FDA’s Guidance for Industry #213
Drivers of AMR and Antibiotic Metabolites in the Environment
Environmental Compartments of AMR and Antibiotic Metabolites
Environmental AMR Surveillance and USG Activities
Notice
Content created by Assistant Secretary for Health (ASH)
Content last reviewed September 18, 2023